Gender (male [%]) | 35 (53.8) | 47 (61) | 0.38 |
Age (years; mean ± standard deviation) | 11 (±3.1) | 10.6 (±3.2) | 0.22 |
Type of seizures: Partial (%) | 47 (72.3) | 55 (71.4) | 0.90 |
Generalized (%) | 18 (27.6) | 22 (28.5) |
Epilepsy syndrome: Idiopathic | 54 (83) | 61 (79.2) | 0.55 |
Symptomatic | 11 (16.9) | 16 (20.7) |
Frequent seizures | 24 (36.9) | 29 (37.6) | 0.92 |
Lobe type seizure: Occipital lobe seizure | 7 (10.7) | 9 (11.6) | 0.86 |
Temporal lobe seizure | 19 (29.2) | 22 (28.5) | 0.93 |
Parietal lobe seizure | 3 (4.6) | 5 (6.4) | 0.68 |
Frontal lobe seizure | 17 (26) | 17 (22) | 0.57 |
Drug used: Carbamazepine | 25 (38.4) | 30 (38.9) | 0.95 |
Levetiracetam | 17 (26) | 18 (23.3) | 0.70 |
Valproic acid | 20 (30.7) | 24 (31) | 0.95 |
Topiramate | 3 (4.6) | 8 (10.3) | 0.22 |
Poly-therapy | 14 (21.5) | 11 (14.2) | 0.25 |
Others anti-epileptic drugs | 13 (20) | 7 (9) | 0.06 |